18 Sep Morphiex to Participate in the 4th Annual Chardan Genetic Medicines Conference
Morphiex Biotherapeutics, a company developing the next generation of CD47 therapeutics for cancer, will participate in the 4th Annual Chardan Genetic Medicines Conference. Our CEO, Dr. Schwartz will be presenting a corporate overview of Morphiex and how its lead asset, MBT-001 is differentiated from competing...